Decreased placental and maternal serum TRAIL-R2 levels are associated with placenta accreta.

Oztas, Efser; Ozler, Sibel; Ersoy, Ali; Ersoy, Ebru; Caglar, Ali; Uygur, Dilek; Yucel, Aykan; Ergin, MERVE; Danisman, Nuri

doi:10.1016/j.placenta.2016.01.004

Decreased placental and maternal serum TRAIL-R2 levels are associated with placenta accreta.

Oztas E., Ozler S., Ersoy A. O., Ersoy E., Caglar A. T., Uygur D., ...Daha Fazla

Placenta, cilt.39, ss.1-6, 2016 (SCI-Expanded, Scopus)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 39
Basım Tarihi: 2016
Doi Numarası: 10.1016/j.placenta.2016.01.004
Dergi Adı: Placenta
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.1-6
Ankara Yıldırım Beyazıt Üniversitesi Adresli: Hayır

Özet

Objectives: TNF-related apoptosis-inducing ligand receptor-2 (TRAIL-R2) is produced both by decidual and trophoblast cells during pregnancy and known to participate in apoptosis. In this study, we aimed to determine and to compare maternal serum and placental TRAIL-R2 levels in patients with placenta accreta, non-adherent placenta previa and in healthy pregnancies. We also aimed to analyze the association of placenta accreta with the occurrence of previous C-sections.